BSN

R3Build Edge Green Apple

F
N+ Score47
Vitamins & MineralsServing: 19 Gram(s)Type: Other Combinations

R3Build Edge Green Apple by BSN is categorized as an 'Other Combinations' supplement, designed as a post-workout or recovery product. Each 19-gram serving includes a 'Recovery Infusion' blend, a 'Myogenic Matrix' at 5.5 grams, and an 'Efforsorb Composite' at 2.4 grams, alongside 160mg of sodium. This product holds an N+ Score of 47, resulting in an 'F' grade and placing it in the below-average tier. The low score reflects limited ingredient adequacy and formula completeness, despite 83% label transparency. Without specific ingredient breakdowns within its proprietary blends, it is challenging to determine if key ingredients are present at clinically relevant dosages. This product may appeal to individuals looking for a general post-exercise recovery blend, but its N+ Score suggests potential for more effective formulations.

About This Product

R3Build Edge Green Apple by BSN is a vitamins & minerals supplement containing 6 active ingredients. It has earned an N+ Score of 47/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency83/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity65/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (6 ingredients)

IngredientAmountDose Adequacy
Calories5.000 Calorie(s)N/A
Total Carbohydrates1.000 Gram(s)N/A
Sodium160.000 mgN/A
Recovery InfusionN/A
Myogenic Matrix5.500 Gram(s)N/A
Efforsorb Composite2.400 Gram(s)N/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.